Product category:
Proteomics
News Release from: Phenomenex | Subject: Beckman Coulter ProteomeLab
Edited by the Laboratorytalk Editorial
Team on 11 June 2007
Distributing IgY proteome enrichment
chemistry
Phenomenex enters a distribution agreement for Beckman Coulter's market-leading ProteomeLab IgY enrichment products for proteomics and biomarker discovery
The agreement grants Phenomenex exclusive distribution rights in the United States, Canada and countries in the European Union Based on avian-generated antibodies, ProteomeLab IgY-12 liquid chromatography and spin columns offer cleaner capture and broader antigen-binding host range than other protein depletion/ partitioning methods because of the evolutionary distance between chickens and mammals
This article was originally published on Laboratorytalk on 1 Jul 2008 at 8.00am (UK)
Related stories
New chiral HPLC/SFC columns from Phenomenex
Lux columns are offered with two chiral stationary phases (CSPs), both of which use coated derivatised cellulose as the chiral selector
RC syringe filters improve chromatography
By removing particulates from the sample, the filters prevent buildup and blockage of chromatography columns and frits while minimising wear and tear on injection valves
"Protein partitioning is a critical part of any biomarker discovery program and we view the ProteomeLab IgY products as the best available," commented Michael McGinley, Phenomenex biochromatography product manager.
"These columns fit well with our portfolio of complete proteomics solutions for the separation of proteins and peptides".
Highly abundant proteins can significantly mask potential markers and impede the discovery of biomarker targets.
ProteomeLab IgY-12 columns selectively partition 12 highly abundant proteins, up to 96% of the protein mass, from human/primate serum, plasma or cerebrospinal fluid.
IgY-R7 columns partition seven highly abundant rodent proteins, while single-component kits specifically capture a choice of seven key highly abundant plasma proteins, enabling a more targeted approach for specific protein partitioning.
IgY delivers an enriched proteome that includes medium- and low-abundance proteins that are of interest to biomarker research.
"The ProteomeLab IgY product line has experienced double digit growth since its introduction in 2005 and we have been looking for ways to make it available to more researchers," commented Jerry Feitelson, business development manager for Beckman Coulter.
"We see Phenomenex as a valuable strategic partner to expand the leadership of this product line in biomarker discovery sample preparation".
"Being specifically focused on consumable separation devices, Phenomenex is ideally suited to best serve the customer's needs," commented Catherine Cordova, Phenomenex biochromatography brand manager.
"Our international network of technical consultants can provide instant support for this product".
The IgY products will continue to be sold under Beckman Coulter's ProteomeLab brand.
• Phenomenex: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
